C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
2.750
-0.080 (-2.83%)
At close: Apr 28, 2026, 4:00 PM EDT
2.760
+0.010 (0.36%)
After-hours: Apr 28, 2026, 7:57 PM EDT
C4 Therapeutics Employees
C4 Therapeutics had 104 employees as of December 31, 2025. The number of employees decreased by 6 or -5.45% compared to the previous year.
Employees
104
Change (1Y)
-6
Growth (1Y)
-5.45%
Revenue / Employee
$345,644
Profits / Employee
-$1,009,558
Market Cap
268.34M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Coherus Oncology | 147 |
| AC Immune | 122 |
| Artiva Biotherapeutics | 104 |
| Editas Medicine | 87 |
| Compugen | 75 |
| Cybin | 50 |
| Protara Therapeutics | 46 |
| Eledon Pharmaceuticals | 33 |
CCCC News
- 19 days ago - C4 Therapeutics, Roche expand partnership with new cancer deal worth over $1 billion - Reuters
- 19 days ago - C4 Therapeutics Expands Long-Term Partnership with Roche Through New Collaboration Agreement Focused on Discovering and Developing Degrader-Antibody Conjugates (DACs) - GlobeNewsWire
- 4 weeks ago - C4 Therapeutics Announces First Patient Dosed in Phase 1b Trial of Cemsidomide in Combination with Elranatamab (ELREXFIO®) for Relapsed/Refractory Multiple Myeloma - GlobeNewsWire
- 7 weeks ago - C4 Therapeutics Transcript: Barclays 28th Annual Global Healthcare Conference - Transcripts
- 7 weeks ago - C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - C4 Therapeutics Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - C4 Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights - GlobeNewsWire
- 2 months ago - C4 Therapeutics to Participate in Upcoming March Conferences - GlobeNewsWire